DDrare
Disease
Drug
Target Gene/Pathway
問合せ先
EN
38. スティーヴンス・ジョンソン症候群
Stevens-Johnson syndrome
Clinical trials
/
Disease details
臨床試験数
:
13
/
薬物数
:
23
- (
DrugBank
:
9
) /
標的遺伝子数
:
15
-
標的パスウェイ数
:
101
Search
1 trial found
10
50
100
ALL
diseases per page:
Showing 1 to 1 of 1 diseases
Filter by
Reset
No.
TrialID
Date_
enrollment
Date_
registration
Public_title
Scientific_title
Condition
Intervention
Primary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
Phase
Countries
1
EUCTR2012-003136-23-GB
(
EUCTR
)
27/11/2012
16/11/2012
Lamotrigine
And Borderline Personality Disorder: Investigating Long-Term Effectiveness
Lamotrigine
And Borderline Personality Disorder: Investigating Long-Term Effectiveness - LABILE
Borderline Personality Disorder
MedDRA version: 14.1;Level: PT;Classification code 10042033;Term: Stevens-Johnson syndrome;System Organ Class: 10040785 - Skin and subcutaneous tissue disorders
MedDRA version: 14.1;Classification code 10019211;Term: Headache;System Organ Class: 10029205 - Nervous system disorders
MedDRA version: 15.0;Level: LLT;Classification code 10028821;Term: Nausea with vomiting;System Organ Class: 100000004856
MedDRA version: 14.1;Classification code 10040913;Term: Skin rash;Classification code 10024264;Term: Lethargy;System Organ Class: 10029205 - Nervous system disorders
MedDRA version: 14.1;Classification code 10013649;Term: Drowsiness;System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
Borderline Personality Disorder
MedDRA version: 14.1;Level: PT;Classification code 10042033;Term: St ...
Trade Name:
Lamotrigine
- generic product
Product Name:
Lamotrigine
Product Code: n/a
INN or Proposed INN:
Lamotrigine
Other descriptive name:
6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
Trade Name:
Lamotrigine
- generic product
Product Name:
Lamotrigine
Product Code: n/a
INN or Proposed IN ...
Imperial College London
NULL
Not Recruiting
Female: yes
Male: yes
252
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (Phase 3): no Therapeutic use (Phase 4): yes
Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...
United Kingdom